Schizophrenia clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, currently not accepting new patients, but might later
The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve symptoms in schizophrenia patients who have residual symptoms despite being on adequate treatment with antipsychotic medication.
Irvine, California and other locations